Current and Emerging Therapies for Follicular Lymphoma: Solving Practice Challenges

By: Annenberg Center for Health Sciences
  • Summary

  • An indolent subtype of non-Hodgkin lymphoma, follicular lymphoma is characterized by eventual relapse of disease and the need for multiple lines of therapy, adding to the significant disease burden experienced by patients. Novel targeted agents in the relapsed/refractory setting have afforded new treatment options, but important clinical challenges exist, including optimal treatment sequencing, therapy evaluation and patient selection, transitions of care requirements, as well as toxicity management.
    Annenberg Center for Health Sciences
    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Solving Practice Challenges in Community-Based Interprofessional Care Teams
    Dec 14 2023

    In this 1-hour, online activity, lymphoma expert Jeremy Abramson, MD, shares his experience navigating these challenges as part of an interprofessional, multidisciplinary care team.

    Show More Show Less
    50 mins

What listeners say about Current and Emerging Therapies for Follicular Lymphoma: Solving Practice Challenges

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.